Immunoreactivity of Intact Virions of Human Immunodeficiency Virus Type 1 (HIV-1) Reveals the Existence of Fewer HIV-1 Immunotypes than Genotypes

In order to protect against organisms that exhibit significant genetic variation, polyvalent vaccines are needed. Given the extreme variability of human immunodeficiency virus type 1 (HIV-1), it is probable that a polyvalent vaccine will also be needed for protection from this virus. However, to und...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Virol
Egile Nagusiak:	Nyambi, Phillipe N., Nádas, Arthur, Mbah, Henry A., Burda, Sherri, Williams, Constance, Gorny, Miroslaw K., Zolla-Pazner, Susan
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 2000
Gaiak:	Pathogenesis and Immunity
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC110941/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11044111/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.74.22.10670-10680.2000
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!